The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

ASH Update on MDS Management: What Are the Outcomes of Venetoclax for Higher Risk MDS? Can We Expect to See Venetoclax + AZA as a New SoC?

166 views
March 5, 2021
Comments 0
Login to view comments. Click here to Login